A case of synchronous herpes zoster infection and leukocytoclastic vasculitis localized to the same dermatome
A case of drug reaction with eosinophilia and systemic symptoms with colitis as a presenting feature [Case Report]
Use of teledermatology by dermatology hospitalists is effective in the diagnosis and management of inpatient disease
BACKGROUND:Patient outcomes are improved when dermatologists provide inpatient consults. Inpatient access to dermatologists is limited, illustrating an opportunity to utilize teledermatology. Little is known about the ability of dermatologists to accurately diagnose and manage inpatients using teledermatology, particularly utilizing non-dermatologist generated clinical data. METHODS:This prospective study assessed the ability of teledermatology to diagnose and manage 41 dermatology consults from a large urban tertiary care center utilizing internal medicine referral documentation and photos. Twenty-seven dermatology hospitalists were surveyed. Interrater agreement was assessed by the kappa statistic. RESULTS:There was substantial agreement between in-person and teledermatology assessment of the diagnosis with differential diagnosis (median kappa = 0.83), substantial agreement in laboratory work-up decisions (median kappa = 0.67), almost perfect agreement in imaging decisions (median kappa = 1.0), and moderate agreement in biopsy decisions (median kappa = 0.43). There was almost perfect agreement in treatment (median kappa = 1.0), but no agreement in follow-up planning (median kappa = 0.0). There was no association between raw photo quality and the primary plus differential diagnosis or primary diagnosis alone. LIMITATIONS/CONCLUSIONS:Selection bias and single-center nature. CONCLUSIONS:Teledermatology may be effective in the inpatient setting, with concordant diagnosis, evaluation, and management decisions.
Chronic hydroxychloroquine therapy and COVID-19 outcomes: A retrospective case-control analysis
Evaluating the Contributions of Dermatologists in the Management of Systemic Sclerosis: A Retrospective Analysis [Letter]
Systemic Sclerosis (SSc) is an autoimmune condition characterized by cutaneous sclerosis and the potential for internal organ involvement.1 Given the multisystem nature of SSc, multiple disciplines are often involved in its management. However, while the skin is affected in more than 90% of patients,2 dermatologists are variably involved in the management of SSc, potentially first evaluating patients only late in the disease course, or at times not at all.
Clinical Characteristics of Lupus Erythematosus Panniculitis/Profundus: A Retrospective Review of 61 Patients
Acrofacial purpura and necrotic ulcerations in COVID-19: a case series from New York City
Willingness-to-pay stated preferences in cutaneous lupus erythematosus: a pilot study
Cutaneous lupus erythematosus (CLE) is a chronic skin disease that significantly impacts quality of life (QOL). This study tested a novel method to measure QOL in CLE using willingness-to-pay (WTP) stated preferences, and aimed to determine which of nine domains of life are most affected by CLE. Twenty-one participants with CLE ranked the domains in order of impact on CLE-related QOL, and then stated how many United States dollars they would be willing to pay for a hypothetical cure for each domain. Eighty-one percent of participants were female; mean age was 42.4Â years. Photosensitivity was ranked highest by 71.4% of respondents. Participants were willing to pay the most for a hypothetical cure for CLE specific to photosensitivity (medianâ€‰=â€‰$200,000), the least for a cure specific to self-care (medianâ€‰=â€‰$0). Participants were willing to pay a median of $1,000,000 for an overall cure for CLE. Limitations include a smallÂ sample size for this pilot study and thatÂ willingness-to-pay may be influenced by individual perception of money and socioeconomic factors. This study successfully pilot-tested a WTP method and ranking task for health-related QOL. Photosensitivity was the domain of life most affected by CLE, which is a domain unique to our novel tool.
Response to "Patient preference for cellulitis treatment: at-home care is preferred to hospital-based treatment" [Letter]
Dermatologists' Role in the Diagnosis and Management of Coronavirus Disease 2019 Coagulopathy [Letter]